First Time Loading...

Zymeworks Inc
NYSE:ZYME

Watchlist Manager
Zymeworks Inc Logo
Zymeworks Inc
NYSE:ZYME
Watchlist
Price: 9.15 USD 1.67% Market Closed
Updated: May 16, 2024

Zymeworks Inc
Interest Income Expense

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Zymeworks Inc
Interest Income Expense Peer Comparison

Comparables:
TH
RPTX
FUSN
AUPH
EDT

Competitive Interest Income Expense Analysis
Latest Figures & CAGR of Competitors

Company Interest Income Expense CAGR 3Y CAGR 5Y CAGR 10Y
Zymeworks Inc
NYSE:ZYME
Interest Income Expense
$18.5m
CAGR 3-Years
36%
CAGR 5-Years
47%
CAGR 10-Years
N/A
Theratechnologies Inc
TSX:TH
Interest Income Expense
-$8.1m
CAGR 3-Years
-19%
CAGR 5-Years
-22%
CAGR 10-Years
N/A
Repare Therapeutics Inc
NASDAQ:RPTX
Interest Income Expense
$13.2m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Fusion Pharmaceuticals Inc
NASDAQ:FUSN
Interest Income Expense
$4.1m
CAGR 3-Years
131%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Aurinia Pharmaceuticals Inc
NASDAQ:AUPH
Interest Income Expense
$13.7m
CAGR 3-Years
157%
CAGR 5-Years
N/A
CAGR 10-Years
34%
Spectral Medical Inc
TSX:EDT
Interest Income Expense
-CA$3.2m
CAGR 3-Years
-373%
CAGR 5-Years
N/A
CAGR 10-Years
N/A

See Also

What is Zymeworks Inc's Interest Income Expense?
Interest Income Expense
18.5m USD

Based on the financial report for Dec 31, 2023, Zymeworks Inc's Interest Income Expense amounts to 18.5m USD.

What is Zymeworks Inc's Interest Income Expense growth rate?
Interest Income Expense CAGR 5Y
47%

Over the last year, the Interest Income Expense growth was 294%. The average annual Interest Income Expense growth rates for Zymeworks Inc have been 36% over the past three years , 47% over the past five years .